Novel pyrido [2,3-f][1,4] thiazepines and pyrido [3,2-b][1,5] benzothiazepines
    1.
    发明公开
    Novel pyrido [2,3-f][1,4] thiazepines and pyrido [3,2-b][1,5] benzothiazepines 失效
    吡啶并(2,3-f)(1,4)硫氮杂与吡啶并(3,2-b)(1,5)苯并硫氮杂。

    公开(公告)号:EP0462696A1

    公开(公告)日:1991-12-27

    申请号:EP91303970.7

    申请日:1991-05-02

    IPC分类号: C07D513/04 A61K31/55

    CPC分类号: C07D513/04

    摘要: Novel pyrido[2,3-f][1,4]thiazepines and novel pyrido[3,2-b][1,5]benzothiazepines are described. These compounds are useful as calcium channel antagonists with cardiovascular, antiasthmatic and antibronchoconstriction activity. Also described are methods of producing the novel compounds and intermediates thereof.

    摘要翻译: 描述了新的吡啶并[2,3-f] [1,4]硫杂吖庚因和新的吡啶并[3,2-b] [1,5]苯并硫氮杂。 这些化合物可用作具有心血管,止喘和抗纤维支配作用的钙通道拮抗剂。 还描述了生产新化合物及其中间体的方法。

    Substituted triazoles as angiotensin II inhibitors
    8.
    发明公开
    Substituted triazoles as angiotensin II inhibitors 失效
    取代三唑仑als血管紧张素II抑制剂。

    公开(公告)号:EP0554107A1

    公开(公告)日:1993-08-04

    申请号:EP93300661.1

    申请日:1993-01-29

    CPC分类号: C07D403/10 C07D249/12

    摘要: This invention relates to novel bis-biphenyl substituted 3-mercapto-1,2,4-tetrazoles and to pharmaceutically acceptable salts thereof.
    The compounds are angiotensin II receptor antagonists, and are useful in treating hypertension (lowering high blood pressure), congestive heart failure, elevated ocular pressure, cerebral stroke, angina, cardiac insufficiency, myocardial infarction or diabetic nephropathy.
    The invention also relates to a pharmaceutical composition comprising a compound of the invention, a method of treating a physiological condition in a mammal that is mediated by angiotensin 11 which comprises administering to the mammal an effective amount of a compound of the invention, and novel processes for preparing the compounds of the invention.

    摘要翻译: 本发明涉及新的双联苯基取代的3-巯基-1,2,4-四唑及其药学上可接受的盐。 这些化合物是血管紧张素II受体拮抗剂,可用于治疗高血压(降低高血压),充血性心力衰竭,眼压升高,脑中风,心绞痛,心功能不全,心肌梗塞或糖尿病肾病。 本发明还涉及包含本发明化合物的药物组合物,治疗由血管紧张素11介导的哺乳动物中的生理状况的方法,其包括给予哺乳动物有效量的本发明化合物和新方法 用于制备本发明的化合物。